But all Highmark is seeking to do is to ensure that physicians use the most cost-effective form of intravenousimmunoglobulin (IVIG) for their patients.
And the NIMH is testing whether giving Pandas patients injections of plasma from healthy donors, intravenousimmunoglobulin (IVIG), can reset their immune systems and for how long.